Press Releases :: Kane Biotech Inc. (KNE)

Skip to main content

Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal

Feb 20, 2026

Kane Biotech Expands Commercial Activities in the United States

Feb 19, 2026

Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser

Feb 17, 2026

Kane Biotech Restarts Commercial Activities and Strengthens North American Management

Feb 12, 2026

Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

Dec 18, 2025

Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

Dec 17, 2025

Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray

Dec 10, 2025

Kane Biotech Announces Third Quarter 2025 Financial Results

Nov 28, 2025

Kane Biotech Announces New Private Placement Offering

Nov 27, 2025

Kane Biotech Presents revyve® Data at Diabetic Foot and Southern Region Burn Conferences

Nov 4, 2025